Kontakt os
Vores team er her for at hjælpe dig med at yde den bedste veterinære pleje gennem levering af produktrådgivning og klinisk case-diskussion.
Anja Bonde
Territory Manager
Veterinærsygeplejerske
e: anja.bonde@boehringer-ingelheim.com
t: +45 20 95 95 01
Ane Skovgaard Rasmussen
Territory Manager
Veterinærsygeplejerske
e: ane.skovgaard_rasmussen@boehringer-ingelheim.com
t: +45 29 74 17 38
Christine Harff Laursen
Territory Manager
Veterinærsygeplejerske
e: christine.harff_laursen@boehringer-ingelheim.com
t: +45 22 72 49 39
Lene Thaulow
Nordic Brand and Technical Manager
Dyrlæge, Feline specialist
e: lene.thaulow@boehringer-ingelheim.com
t: +45 22 72 48 34
Indhold der kan downloades
Vi har en række materialer som du kan downloade eller bestille i Vetportal (åbnes i nyt vindue)
- 1. Niessen, S. J. M. et al. (2022) Once daily oral therapy for feline diabetes mellitus: evaluation of SGLT-2 inhibitor velagliflozin as stand-alone therapy compared to insulin injection therapy in diabetic cats. Journal of Veterinary Internal Medicine 36, 2512–2513.
- 2. Sparkes, A. H. et al. (2015) ISFM Consensus Guidelines on the Practical Management of Diabetes Mellitus in Cats. J Feline Med Surg 17, 235–50.
- 3. McCann, T., et al. (2007) Feline diabetes mellitus in the UK: the prevalence within an insured cat population and a questionnaire-based putative risk factor analysis. J Feline Med Surg 9, 289–9.
- 4. O’Neill, D., et al. (2016) Epidemiology of Diabetes Mellitus among 193,435 Cats Attending Primary-Care Veterinary Practices in England. J Vet Intern Med 30, 964–72.
- 5. Rand J, Gottlieb, SA. Feline diabetes mellitus. Textbook of Veterinary Internal Medicine, 8th edition. Ettinger SJ, Feldman EC and Cote E, eds. Elsevier, Missouri. 2017;1781-1795.
- 6. 2018 Summary of the Veterinary Clinic: Pet Obesity Prevalence Survey & Pet Owner: Weight Management, Nutrition, and Pet Food Survey. Available at:
https://petobesityprevention.org/2018. - 7. Niessen, S. J. M. et al. (2017) The Big Pet Diabetes Survey: Perceived Frequency and Triggers for Euthanasia. Vet Sci 4, 27.
- 8. Diabetes in Cats: Quantitative market research study. Proprietary presentation, July 19, 2021. Kynetec; St. Louis, MO, on behalf of Boehringer Ingelheim.
- 9. Niessen, S. J. M. et al. (2010) Evaluation of a quaility-of-life tool for cats with diabetes mellitus. J Vet Intern Med 24, 1098-105.
- 10. Behrend, E. N. et al. (2023) Velagliflozin, an SGLT2 Inhibitor, as a once-daily, oral solution, stand-alone therapy for feline diabetes mellitus. Oral abstract presentation, 2023 ACVIM Forum, Pennsylvania, Jun 15-17.
- 11. Niessen, S. J. M. et al. (2023) Efficacy and safety of once daily oral sodium-glucose co-transporter-2-inhibitor velagliflozin compared to twice daily insulin injection therapy in diabetic cats. Oral abstract presentation, 2023 ECVIM-CA Forum, Barcelona, Sept 21-23.
- 12. Produktresumé Senvelgo® 15 mg/ml. 2023-12-13.
- 13. CM Research (2022) Small animal vets UK April 2022. Syndicated Sales Rep Survey.